Trial · NCT00782288
Adverse events111
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 111
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | abdominal pain | Gastrointestinal disorders | Placebo | 2 | 8 | 4 |
| other | abdominal pain | Gastrointestinal disorders | Low Dose 0.05 mg Digitoxin | 1 | 8 | 1 |
| other | abdominal pain | Gastrointestinal disorders | Higher Dose 0.1mg Digitoxin | 1 | 8 | 1 |
| other | anxiety | Nervous system disorders | Placebo | 0 | 8 | 0 |
| other | anxiety | Nervous system disorders | Low Dose 0.05 mg Digitoxin | 1 | 8 | 1 |
| other | anxiety | Nervous system disorders | Higher Dose 0.1mg Digitoxin | 0 | 8 | 0 |
| other | chills | Infections and infestations | Placebo | 1 | 8 | 1 |
| other | chills | Infections and infestations | Low Dose 0.05 mg Digitoxin | 0 | 8 | 0 |
| other | chills | Infections and infestations | Higher Dose 0.1mg Digitoxin | 0 | 8 | 0 |
| other | cough | Respiratory, thoracic and mediastinal disorders | Placebo | 2 | 8 | 2 |
| other | cough | Respiratory, thoracic and mediastinal disorders | Low Dose 0.05 mg Digitoxin | 2 | 8 | 2 |
| other | cough | Respiratory, thoracic and mediastinal disorders | Higher Dose 0.1mg Digitoxin | 2 | 8 | 2 |
| other | crackles | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 8 | 1 |
| other | crackles | Respiratory, thoracic and mediastinal disorders | Low Dose 0.05 mg Digitoxin | 1 | 8 | 2 |
| other | crackles | Respiratory, thoracic and mediastinal disorders | Higher Dose 0.1mg Digitoxin | 0 | 8 | 0 |
| other | decrease breath sounds | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 8 | 0 |
| other | decrease breath sounds | Respiratory, thoracic and mediastinal disorders | Low Dose 0.05 mg Digitoxin | 1 | 8 | 1 |
| other | decrease breath sounds | Respiratory, thoracic and mediastinal disorders | Higher Dose 0.1mg Digitoxin | 0 | 8 | 0 |
| other | decreased lung function | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 8 | 0 |
| other | decreased lung function | Respiratory, thoracic and mediastinal disorders | Low Dose 0.05 mg Digitoxin | 1 | 8 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00782288/events